MedTrace Logo

Pilot Study of Nicotine Replacement for Smoking Cessation During Pregnancy

NCT00888979 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-01-09

Study results available
· View outcomes & findings →

Summary

We plan to examine the feasibility, acceptability, preliminary quit rates, overall nicotine exposure and adverse effects of the nicotine inhaler for smoking cessation in pregnancy.

Conditions

  • Tobacco Use Disorder

Interventions

DRUG

Nicotrol Inhaler

10 mg of nicotine per one inhaler cartridge. Inhaler use will substitute the usual smoking pattern

Sponsors & Collaborators

  • UConn Health

    collaborator OTHER

  • Hartford Hospital

    lead OTHER

Principal Investigators

  • Cheryl Oncken, MD MPH · UConn Health

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2011-05-31
Completion
2014-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00888979 on ClinicalTrials.gov